It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Citrullination is the conversion of arginine-to-citrulline by protein arginine deiminases (PADs), whose dysregulation is implicated in the pathogenesis of various types of cancers and autoimmune diseases. Consistent with the ability of human cytomegalovirus (HCMV) to induce post-translational modifications of cellular proteins to gain a survival advantage, we show that HCMV infection of primary human fibroblasts triggers PAD-mediated citrullination of several host proteins, and that this activity promotes viral fitness. Citrullinome analysis reveals significant changes in deimination levels of both cellular and viral proteins, with interferon (IFN)-inducible protein IFIT1 being among the most heavily deiminated one. As genetic depletion of IFIT1 strongly enhances HCMV growth, and in vitro IFIT1 citrullination impairs its ability to bind to 5’-ppp-RNA, we propose that viral-induced IFIT1 citrullination is a mechanism of HCMV evasion from host antiviral resistance. Overall, our findings point to a crucial role of citrullination in subverting cellular responses to viral infection.
Citrullination is a posttranslational modification of arginines. Here, the authors show that HCMV infection increases citrullination of host and virus proteins to promote infection and that citrullinated interferon-inducible protein IFIT1 is impaired in RNA binding, as a potential mechanism of evasion.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 University of Turin, Department of Public Health and Pediatric Sciences, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)
2 University of Turin, Department of Public Health and Pediatric Sciences, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580)
3 UMass Medical School, Department of Biochemistry and Molecular Pharmacology, Worcester, USA (GRID:grid.168645.8) (ISNI:0000 0001 0742 0364); Boston College, Department of Chemistry, Chestnut Hill, USA (GRID:grid.208226.c) (ISNI:0000 0004 0444 7053)
4 UMass Medical School, Department of Biochemistry and Molecular Pharmacology, Worcester, USA (GRID:grid.168645.8) (ISNI:0000 0001 0742 0364)
5 Boston College, Department of Chemistry, Chestnut Hill, USA (GRID:grid.208226.c) (ISNI:0000 0004 0444 7053)
6 University Medical Center Utrecht, Department of Medical Microbiology, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352)
7 Ulm University Medical Center, Institute of Virology, Ulm, Germany (GRID:grid.410712.1)
8 Technical University of Munich, Institute of Virology, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
9 Blavatnik Institute, Harvard Medical School, Department of Biological Chemistry & Molecular Pharmacology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
10 University of Turin, Department of Public Health and Pediatric Sciences, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); University of Piemonte Orientale, CAAD Center for Translational Research on Autoimmune and Allergic Disease, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741)